We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNCH
5151
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$4K ﹤0.01%
297
-121
-29% -$1.61K
KSPN
5152
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$4K ﹤0.01%
6,057
GVCI
5153
DELISTED
Green Visor Financial Technology Acquisition Corp. I Class A Ordinary Shares
GVCI
$4K ﹤0.01%
423
+108
+34% +$1.13K
TRAQ.U
5154
DELISTED
Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant
TRAQ.U
$4K ﹤0.01%
424
GEEX
5155
DELISTED
Games & Esports Experience Acquisition Corp. Class A Ordinary Shares
GEEX
$4K ﹤0.01%
398
+228
+134% +$2.38K
GLS
5156
DELISTED
Gelesis Holdings, Inc.
GLS
$4K ﹤0.01%
26,871
+10,246
+62% +$2.94K
IONM
5157
DELISTED
Assure Holdings Corp. Common Stock
IONM
$4K ﹤0.01%
72
+38
+112% +$3.77K
HTGM
5158
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$4K ﹤0.01%
1,481
-5,208
-78% -$19.8K
BLPH
5159
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$4K ﹤0.01%
486
-5,386
-92% -$18.8K
IRRX.U
5160
DELISTED
Integrated Rail and Resources Acquisition Corp. Units, each consisting of one share of Class A common stock and one half of one redeemable warrant
IRRX.U
$4K ﹤0.01%
329
CEMI
5161
DELISTED
Chembio diagnostics, Inc.
CEMI
$4K ﹤0.01%
9,810
-24
-0.2% -$9
RACY
5162
DELISTED
Relativity Acquisition Corp. Class A Common Stock
RACY
$4K ﹤0.01%
290
+200
+222% +$3.07K
ACB
5163
Aurora Cannabis
ACB
$235M
$3K ﹤0.01%
442
+397
+882% +$3.47K
AEMD icon
5164
Aethlon Medical
AEMD
$1.54M
$3K ﹤0.01%
2
AGZD icon
5165
WisdomTree Trust WisdomTree Interest Rate Hedged US Aggregate Bond Fund
AGZD
$136M
$3K ﹤0.01%
158
-1,588
-91% -$34.7K
AIA icon
5166
iShares Asia 50 ETF
AIA
$5.07B
$3K ﹤0.01%
+47
New +$2.9K
AOTG icon
5167
AOT Growth and Innovation ETF
AOTG
$104M
$3K ﹤0.01%
98
AP icon
5168
Ampco-Pittsburgh
AP
$190M
$3K ﹤0.01%
1,106
-4,241
-79% -$12.1K
ATNM icon
5169
Actinium Pharmaceuticals
ATNM
$30.2M
$3K ﹤0.01%
336
-100
-23% -$1.06K
BCV
5170
Bancroft Fund
BCV
$144M
$3K ﹤0.01%
204
BSBR icon
5171
Santander
BSBR
$43.2B
$3K ﹤0.01%
471
-229
-33% -$1.24K
BSV icon
5172
Vanguard Short-Term Bond ETF
BSV
$45.7B
$3K ﹤0.01%
45
-132
-75% -$10K
CAAP icon
5173
Corporacion America
CAAP
$6.42B
$3K ﹤0.01%
254
+237
+1,394% +$2.25K
CHIQ icon
5174
Global X MSCI China Consumer Discretionary ETF
CHIQ
$120M
$3K ﹤0.01%
162
CKX icon
5175
CKX Lands
CKX
$21.8M
$3K ﹤0.01%
352
-248
-41% -$2.44K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.